Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

NCT07104955 | Recruiting

• 2 other identifiers: Salutare 01/2024IRAS 347710
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases. This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.

Conditions

Cancer (Solid Tumors); Sarcoma

Keywords

digital health; digital health intervention; multi-disciplinary team meeting; MDT; digital health technology; referral; software

Outcome Measures

Primary Outcomes (3)

• One Referral system safety in facilitating effective MDT meetings

  MDT panel participant feedback on safety and operational incidents

  8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs

• One Referral system implementation feasibility in facilitating effective MDT meetings

  MDT panel participant feedback on effectiveness (non-validated questionnaire)

  8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs

• One Referral system acceptability to MDT panel members acceptability in facilitating

  MDT panel participant feedback on acceptability (Software Usability Scale 0-100, higher score indicate a better outcome)

  8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs

Study Arms (1)

One Referral Group

OTHER

The study arm activities include: 1. Pre-intervention phase: standard multi-disciplinary (MDT) process (without One Referral), baseline MDT meeting observation data collection, participants confirm informed consent and complete baseline survey. 2. Onboarding phase: participants receive training on how to use the One Referral software and complete onboarding survey.. 3. Intervention phase: One Referral software is used as part of the MDT referral and review processes, MDT meeting observation data collection, participants complete intervention survey. 4. Post-intervention phase: standard MDT process (without One Referral), follow-up MDT meeting observation data collection, participants complete offboarding survey

Other: MDT referral and review software

Interventions

MDT referral and review software OTHER

Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals

One Referral Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study.

You may not qualify if:

• MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.

Sponsors & Collaborators

• Salutare Group Ltd.: lead

Study Sites (1)

Royal National Orthopaedic Hospital

London, HA7 4LP, United Kingdom

RECRUITING

MeSH Terms

Conditions

Neoplasms; Sarcoma

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type

Study Officials

• Kevin Moore, MD

  Salutare Limited

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Liba Stones, MA, MBA

CONTACT

+447443940319; liba@dicro.co.uk

Chris Dial

CONTACT

+447759521985; chris@salutare.co.uk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Model Details: Prospective Before and After Study

Study Record Dates

• First Submitted: June 18, 2025
• First Posted: August 5, 2025
• Study Start: July 31, 2025
• Primary Completion (Estimated): June 19, 2026
• Study Completion (Estimated): July 19, 2026
• Last Updated: August 5, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will share

Locations

GB (1)